首页> 外国专利> treatment of genital warts with a combination of liquid nitrogen and recombinant dna human alpha interferon

treatment of genital warts with a combination of liquid nitrogen and recombinant dna human alpha interferon

机译:液氮和重组dna人α干扰素联合治疗尖锐湿疣

摘要

Condylomata acuminata infections (anogenital warts) are treated in infected patients by use of a combined therapy, i.e. by administering liquid nitrogen and immediately thereafter beginning administering recombinant DNA human alpha interferon thrice a week for three weeks. The pharmaceutical composition of interferon for use in the combined therapy contains recombinant DNA human interferon alfa-2b in which 1.0 X 106 International Units are administered by injection to each lesion. The liquid nitrogen is the cryosurgical agent exemplified and it is topically administered to each lesion by conventional means. The use of human alpha interferon for the manufacture of a medicament for use in the combined therapy exemplified is also disclosed.
机译:通过联合治疗,即通过施用液氮,然后立即开始每周三次施用重组DNA人α干扰素,连续三周,以治疗合并感染的患者的尖锐湿疣(肛门生殖器疣)。用于联合治疗的干扰素的药物组合物包含重组DNA人干扰素α-2b,其中通过注射至每个病变施用1.0×10 6国际单位。液氮是示例性的冷冻治疗剂,并且通过常规方式将其局部施用于每个病变。还公开了人α干扰素在制备用于示例性联合疗法中的药物中的用途。

著录项

  • 公开/公告号DK79591D0

    专利类型

  • 公开/公告日1991-04-30

    原文格式PDF

  • 申请/专利权人 SCHERING CORP;

    申请/专利号DK19910000795

  • 申请日1991-04-30

  • 分类号A61K37/66;

  • 国家 DK

  • 入库时间 2022-08-22 05:58:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号